-
Mashup Score: 27
The current GI workforce can’t meet patient demand, and private practices in particular face challenges in keeping physicians.
Source: www.medscape.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 2Older adults with Crohn’s at risk for postop recurrence, benefit from biologic prophylaxis - 24 day(s) ago
SAN DIEGO — Older patients with Crohn’s disease are at elevated risk for recurrence following ileocolic resection but less frequently receive postoperative prophylactic biologics, according to research presented at Digestive Disease Week.These findings underscore the importance of considering treatment regardless of age, according to co-author Miguel Regueiro, MD, chief of the
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
💊 😷 Older patients with Crohn’s have high risk for recurrence after ileocolic resection but less often receive postop prophylactic biologics, according to a study presented at @DDWMeeting by @MRegueiroMD of @ClevelandClinic. #DDW2025 https://t.co/RyRysgJwfn
-
-
Mashup Score: 3ERCP makes ‘no difference’ in acute pancreatitis risk for patients with pancreas divisum - 28 day(s) ago
SAN DIEGO — Patients with pancreas divisum did not experience reduced risk for acute pancreatitis after endoscopic retrograde cholangiopancreatography with sphincterotomy, according to study results presented at Digestive Disease Week.Patients with pancreas divisum, a common anatomic variant, who have acute recurrent pancreatitis have been treated with ERCP with minor papilla endoscopic
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
🔬 New results from the SHARP trial show ERCP with minor papilla sphincterotomy does not reduce acute pancreatitis risk in patients with pancreas divisum. Despite a 40-year practice, outcomes were similar between ERCP and sham groups. #DDW2025 @DDWMeeting https://t.co/nmR2Qt2upn
-
-
Mashup Score: 1Older adults with Crohn’s at risk for postop recurrence, benefit from biologic prophylaxis - 1 month(s) ago
SAN DIEGO — Older patients with Crohn’s disease are at elevated risk for recurrence following ileocolic resection but less frequently receive postoperative prophylactic biologics, according to research presented at Digestive Disease Week.These findings underscore the importance of considering treatment regardless of age, according to co-author Miguel Regueiro, MD, chief of the
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
💊 😷 Older patients with Crohn’s have high risk for recurrence after ileocolic resection but less often receive postop prophylactic biologics, according to a study presented at @DDWMeeting by @MRegueiroMD of @ClevelandClinic. #DDW2025 https://t.co/RyRysgJwfn
-
-
Mashup Score: 0
Phase 3 data link gut microbiome shifts to better mental health outcomes in patients treated with fecal microbiota, live-jslm
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
In this interview, Dr. Paul Feuerstadt from @YaleMed discusses new phase 3 data showing that fecal microbiota, live-jslm (Rebyota) may improve mental quality of life in C difficile patients. #DDW2025 @DDWMeeting Listen here: https://t.co/94FgQIbSeT https://t.co/zHSONqfktz
-
-
Mashup Score: 5
A pair of experts discuss their research on trends in the use of GLP-1 RAs in patients with IBD as well as their safety and efficacy in this patient population.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
We spoke with @GimdGold and @pedsIBDdoc about their research on GLP-1 RA use in patients with IBD, presented at #DDW2025. Full interview: https://t.co/f84pC9bh8E https://t.co/A3s74IP2qK
-
-
Mashup Score: 2ERCP makes ‘no difference’ in acute pancreatitis risk for patients with pancreas divisum - 1 month(s) ago
SAN DIEGO — Patients with pancreas divisum did not experience reduced risk for acute pancreatitis after endoscopic retrograde cholangiopancreatography with sphincterotomy, according to study results presented at Digestive Disease Week.Patients with pancreas divisum, a common anatomic variant, who have acute recurrent pancreatitis have been treated with ERCP with minor papilla endoscopic
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
🔬 New results from the SHARP trial show ERCP with minor papilla sphincterotomy does not reduce acute pancreatitis risk in patients with pancreas divisum. Despite a 40-year practice, outcomes were similar between ERCP and sham groups. #DDW2025 @DDWMeeting https://t.co/nmR2Qt2upn
-
-
Mashup Score: 14Home Page: AGA Journals - 1 month(s) ago
Published online: December 19, 2024 Published online: July 3, 2024 Published online: December 27, 2024 Published online: January 24, 2025 Published online: November 22, 2024 Adherence to MED is associated with beneficial clinical outcomes and decreased inflammatory markers. These may be driven by lower levels of primary bil e acids and microbial dysbiosis and a beneficial microbial and metabolite composition. Randomized controlled trials are needed to evaluate the role of MED in CD management. This
Source: www.agajournals.orgCategories: General Medicine News, GastroenterologyTweet-
The @AmerGastroAssn journal editors loved seeing you at #DDW2025 ✅ Thank you to all who stopped by to meet the editors! 🤝 We can’t wait until to read your manuscript 📜 For more about the AGA journals: https://t.co/Kfb8Wii7xc https://t.co/OlMvAxGeH1
-
-
Mashup Score: 10Resources for reviewers | Elsevier - 1 month(s) ago
Guiding you through each stage of the review process with a selection of resources, tips and tricks to enhance your reviewing experience with Elsevier.
Source: www.elsevier.comCategories: General Medicine News, GastroenterologyTweet-
Thank you to everyone who attended the @AmerGastroAssn reviewer session as part of #DDW2025 👩⚕️📖 Please don't hesitate to reach out if you would like to learn more about getting involved with peer review! 💡 Additional resources: https://t.co/c0TyAgj9JE https://t.co/RGpLRkwx3P https://t.co/D0WKbAZzOB
-
-
Mashup Score: 0Five-protein model predicts MASLD with ‘strong accuracy’ up to 16 years before onset - 1 month(s) ago
Five plasma proteins may predict a patient’s risk for metabolic dysfunction-associated steatotic liver disease up to 16 years before symptoms develop, according to research presented at Digestive Disease Week.“Among more than 2,700 proteins, five stood out,” Shiyi Yu, MD, resident physician in the department of gastroenterology at Guangdong Provincial People’s Hospital in
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
Five plasma proteins may predict a patient’s risk for metabolic dysfunction-associated steatotic liver disease up to 16 years before symptoms develop, according to research presented at @DDWMeeting. #DDW2025 https://t.co/RzCUchGVtL
-
Thank you @Medscape for highlighting our session from @AmerGastroAssn @DDWMeeting #DDW2025 Winning Strategies to Retain Gastroenterologists and Recruit Young Gastroenterologists 📖https://t.co/767wC3Obig ✅Flexibilty ✅Autonomy ✅Value ✅Transparency ✅Growth opportunities https://t.co/uvfdrc9vE9